Exscientia (EXAI)
(Delayed Data from NSDQ)
$5.28 USD
-0.03 (-0.56%)
Updated Nov 7, 2024 04:00 PM ET
After-Market: $5.30 +0.02 (0.38%) 6:40 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
View All Zacks #1 Ranked StocksExscientia PLC Sponsored ADR (EXAI) Price Targets
| Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
|---|---|---|---|
| $6.23 | $8.00 | $5.00 | 17.33% |
Price Target
Based on short-term price targets offered by three analysts, the average price target for Exscientia PLC Sponsored ADR comes to $6.23. The forecasts range from a low of $5.00 to a high of $8.00. The average price target represents an increase of 17.33% from the last closing price of $5.31.
Analyst Price Targets (3 )
Broker Rating
Exscientia PLC Sponsored ADR currently has an average brokerage recommendation (ABR) of 3.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by four brokerage firms. The current ABR compares to an ABR of 3.00 a month ago based on four recommendations.
Broker Rating Breakdown
Brokerage Recommendations
| Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 4 | 4 | 4 | 4 | 4 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| ABR | 3.00 | 3.00 | 3.00 | 3.00 | 3.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
| Date | Brokerage Firm | Analyst | Previous | Current |
|---|---|---|---|---|
| 8/13/2024 | Not Identified | Not Identified | Strong Buy | Hold |
| 8/9/2024 | Cowen & Co. | Brendan Smith | Strong Buy | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
| Current ABR | 3.00 |
| ABR (Last week) | 3.00 |
| # of Recs in ABR | 4 |
| Average Target Price | $6.23 |
| LT Growth Rate | 13.50% |
| Industry | Medical - Drugs |
| Industry Rank by ABR | 81 of 252 |
| Current Quarter EPS Est: | -0.30 |
EXAI FAQs
Exscientia PLC Sponsored ADR (EXAI) currently has an average brokerage recommendation (ABR) of 3.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 4 brokerage firms.
The average price target for Exscientia PLC Sponsored ADR (EXAI) is $6.23. The current on short-term price targets is based on 2 reports.
The forecasts for Exscientia PLC Sponsored ADR (EXAI) range from a low of $5 to a high of $8. The average price target represents a increase of $17.33 from the last closing price of $5.31.
The current UPSIDE for Exscientia PLC Sponsored ADR (EXAI) is 17.33%
Based on short-term price targets offered by three analysts, the average price target for Exscientia PLC Sponsored ADR comes to $6.23. The forecasts range from a low of $5.00 to a high of $8.00. The average price target represents an increase of 17.33% from the last closing price of $5.31.